Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

A rare case of Cushing's syndrome and pheochromocytoma requires careful re-evaluation to avoid complications.

AMT may cause hair loss and changing dWAT activity could help treat it.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

DHT is crucial for urethral formation, and its disruption can affect masculinization and lead to hypospadias.

Metformin helps induce ovulation in obese women with PCOS, but weight loss is still the main treatment.

The study concluded that hirsutism is most common in women aged 14 to 48, often caused by PCOS, and can be effectively treated with Nd YAG laser and IPL.

Cyproterone acetate and ethinylestradiol significantly lowered AMH levels in PCOS patients resistant to clomiphene.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

Finasteride effectively reduces excess hair in women with certain conditions.

A woman's excessive hair growth around a leg ulcer was linked to a treatment with Prostaglandin E1 ointment.

PCOS women have more arm fat and higher insulin resistance and glucose levels than non-PCOS women.

Different growth patterns in thyroid tumors are influenced by where cell growth and death occur.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

High levels of male hormones in women with PCOS can lead to fertility issues and symptoms like irregular periods, hair growth, acne, and hair loss; lifestyle changes are recommended for management.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

AMH is a promising biomarker for diagnosing PCOS.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Six months of treatment improved PCOS symptoms and reduced AMH levels.

Older age and prostatic hyperplasia in males increase the risk of hemorrhagic cystitis after stem cell transplantation.

Hormonal intrauterine devices (IUDs) may cause or worsen skin conditions influenced by androgens.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Epithelial elements in superficial angiomyxomas are non-neoplastic growths mimicking embryogenesis.

Hormonal treatments affect cow fertility and early embryo development.

Doppler ultrasonography can effectively detect blood flow changes in women with PCOS.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Tumescent liposuction is safe and effective for different cosmetic surgeries if done within recommended limits.

AI can improve early diagnosis and classification of PCOS, aiding in prevention of related health issues.